issues

Akari Therapeutics Issues 2025 End of Year Letter to Shareholders

December 30, 2025 09:15 ET  | Source: Akari Therapeutics Plc TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) --…

4 weeks ago

AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program

DOVER, DE, Dec. 17, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (NASDAQ: ATON) ("AlphaTON" or the "Company"), a publicly traded…

1 month ago

14th Olympic Summit on 11 December 2025 Information for the media

05 December 2025 - The International Olympic Committee (IOC) will host the 14th Olympic Summit on 11 December 2025 in Lausanne,…

2 months ago

Cribl Supercharges Incident Response in Amazon Security Hub with Open Cybersecurity Schema Framework (OCSF) Support

Enhanced capability in Cribl Stream transforms disparate security findings into a standardized format, accelerating threat correlation and resolution December 02,…

2 months ago

vHive Launches Real-Time Solution to Validate As-Built Installations for MNOs

NEW YORK, Dec. 2, 2025 /PRNewswire/ -- vHive, a global leader in infrastructure digitization, announces the launch of On-Site Validation, the…

2 months ago

NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey Breeding Practices

WASHINGTON, Nov. 19, 2025 /PRNewswire/ -- The Standing Committee of CITES, an international body responsible for monitoring trade in animal…

2 months ago

IOC and Samsung celebrate Solve for Tomorrow, Sport & Tech winners in Milan

05 November 2025 - Five outstanding teams were celebrated in Milan on 30 October 2025 as European winners in Samsung’s Solve…

3 months ago

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business

COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…

3 months ago

GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies

The formal safety review of Cohort 3 (5ug/kg/day) has been successfully completed with no safety or tolerability issues observed, allowing…

3 months ago

CORRECTION Algae-C Acquisition by Rockcliffe Labs

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today issues a correction to its earlier release announcing its…

4 months ago